Original Antigenic Sin and Respiratory Syncytial Virus Vaccines

被引:9
|
作者
Tripp, Ralph A. [1 ]
Power, Ultan F. [2 ]
机构
[1] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA
[2] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland
基金
英国生物技术与生命科学研究理事会;
关键词
original antigenic sin; OAS; RSV; vaccines; vaccine effectiveness; VE; immunological memory; PULMONARY INFLAMMATORY RESPONSE; COTTON RATS; PROTECTIVE EFFICACY; BBG2NA VACCINE; FUSION PROTEIN; RSV; IMMUNIZATION; DISEASE; CHALLENGE; INFECTION;
D O I
10.3390/vaccines7030107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The original antigenic sin (OAS) theory considers the outcome of the first encounter with an antigen. It favors a memory response to the original antigen upon exposure to a similar or related antigen, and includes both positive and negative impacts of past exposure on the memory response to challenge, and, in particular, on vaccine efficacy. This phenomenon is closely linked with imprinting and the hierarchical nature of immune responses to previously encountered antigens. The focus of this commentary centers on the potential role of OAS or immunological imprinting on respiratory syncytial virus memory responses.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies
    Arevalo, Claudia P.
    Le Sage, Valerie
    Bolton, Marcus J.
    Eilola, Theresa
    Jones, Jennifer E.
    Kormuth, Karen A.
    Nturibi, Eric
    Balmaseda, Angel
    Gordon, Aubree
    Lakdawala, Seema S.
    Hensley, Scott E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (29) : 17221 - 17227
  • [42] Original antigenic sin in dengue revisited
    Zompi, Simona
    Harris, Eva
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (22) : 8761 - 8762
  • [43] Preparing for the future implementation of respiratory syncytial virus vaccines
    Williams, Thomas C.
    Kim, Sonnie
    Spiro, David J.
    Campbell, Harry
    LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 233 - 235
  • [44] Challenges and Opportunities for Respiratory Syncytial Virus Vaccines Preface
    Anderson, Larry J.
    Graham, Barney S.
    CHALLENGES AND OPPORTUNITIES FOR RESPIRATORY SYNCYTIAL VIRUS VACCINES, 2013, 372 : V - VII
  • [45] Live-Attenuated Respiratory Syncytial Virus Vaccines
    Karron, Ruth A.
    Buchholz, Ursula J.
    Collins, Peter L.
    CHALLENGES AND OPPORTUNITIES FOR RESPIRATORY SYNCYTIAL VIRUS VACCINES, 2013, 372 : 259 - 284
  • [46] Prospects for defined epitope vaccines for respiratory syncytial virus
    Anderson, Robert
    Huang, Yan
    Langley, Joanne M.
    FUTURE MICROBIOLOGY, 2010, 5 (04) : 585 - 602
  • [47] Original Antigenic Sin: How Original? How Sinful?
    Yewdell, Jonathan W.
    Santos, Jefferson J. S.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2021, 11 (05):
  • [48] Vaccines for Respiratory Syncytial Virus Prevention in Older Adults
    Wroblewski, Daniel
    Brust-Sisti, Lindsay A.
    Bridgeman, Matthew
    Bridgeman, Mary Barna
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (12) : 1218 - 1228
  • [49] Development of respiratory syncytial virus (RSV) vaccines for infants
    Gerretsen, Hannah E.
    Sande, Charles J.
    JOURNAL OF INFECTION, 2017, 74 : S143 - S146
  • [50] ORIGINAL ANTIGENIC SIN TO INFLUENZA IN RATS
    ANGELOVA, LA
    SHVARTSMAN, YS
    IMMUNOLOGY, 1982, 46 (01) : 183 - 188